ReviewEuropean journal of medical research2025

Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) to tackle central nervous system diseases: role as a promising approach.

Xiaoxiao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.